| Università di Padova

Avvio procedimento per l’individuazione di complessivi sei componenti interni ed esterni all’Università di Padova di cui almeno due esperti in materia di valutazione - triennio 2022 - 2025

Submitted by stefano.zampieri on Mer, 13/07/2022 - 09:31

Array ( [field_titolo_frontend] => Array ( [#theme] => field [#weight] => -4 [#title] => Titolo frontend [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_titolo_frontend [#field_type] => text_long [#field_translatable] => 0 [#entity_type] => node [#bundle] => elemento_accordion [#object] => stdClass Object ( [vid] => 398292 [uid] => 32 [title] => Avvio procedimento per l’individuazione di complessivi sei componenti interni ed esterni all’Università di Padova di cui almeno due esperti in materia di valutazione - triennio 2022 - 2025 [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 91139 [type] => elemento_accordion [language] => it [created] => 1657697469 [changed] => 1678797364 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1678797364 [revision_uid] => 4 [taxonomy_vocabulary_8] => Array ( ) [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

[safe_summary] => ) ) [#formatter] => text_summary_or_trimmed [0] => Array ( [#markup] =>

Presentazione candidature prorogata al 30 settembre 2022

) ) [field_allegato_element] => Array ( [#theme] => field [#weight] => -2 [#title] => Elemento allegato [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_allegato_element [#field_type] => node_reference [#field_translatable] => 0 [#entity_type] => node [#bundle] => elemento_accordion [#object] => stdClass Object ( [vid] => 398292 [uid] => 32 [title] => Avvio procedimento per l’individuazione di complessivi sei componenti interni ed esterni all’Università di Padova di cui almeno due esperti in materia di valutazione - triennio 2022 - 2025 [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 91139 [type] => elemento_accordion [language] => it [created] => 1657697469 [changed] => 1678797364 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1678797364 [revision_uid] => 4 [taxonomy_vocabulary_8] => Array ( ) [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

Presentazione candidature prorogata al 30 settembre 2022

[summary] => [format] => 2 [safe_value] =>

Presentazione candidature prorogata al 30 settembre 2022

2022RUA02 Allegato 1 - Verbale 3 - Giudizi analitici

Submitted by carriere.docenti on Mer, 13/07/2022 - 09:28

Risultati SA 12 luglio 2022

Submitted by organi on Mar, 12/07/2022 - 19:17

Calendario esame di stato 2023 - Agronomo e Forestale Iunior

Submitted by francesca.forzan on Mar, 12/07/2022 - 16:37

Calendario esame di stato 2023 - Dottore Agronomo e Dottore Forestale

Submitted by francesca.forzan on Mar, 12/07/2022 - 16:36

Unipd is part of the international research team paving the way for the development of new pharmaceuticals

Submitted by francesca.forzan on Mar, 12/07/2022 - 15:43

Array ( [field_link_esterno_news] => Array ( [#theme] => field [#weight] => -1 [#title] => Link esterno news [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_link_esterno_news [#field_type] => text_long [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 398236 [uid] => 2032 [title] => Unipd is part of the international research team paving the way for the development of new pharmaceuticals [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 91132 [type] => box_lancio_news [language] => it [created] => 1657633383 [changed] => 1657633383 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1657633383 [revision_uid] => 2032 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[safe_summary] => ) ) [#formatter] => text_summary_or_trimmed [0] => Array ( [#markup] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

) ) [field_img_box_lancio_news] => Array ( [#theme] => field [#weight] => 0 [#title] => Immagine [#access] => 1 [#label_display] => above [#view_mode] => teaser [#language] => und [#field_name] => field_img_box_lancio_news [#field_type] => image [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 398236 [uid] => 2032 [title] => Unipd is part of the international research team paving the way for the development of new pharmaceuticals [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 91132 [type] => box_lancio_news [language] => it [created] => 1657633383 [changed] => 1657633383 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1657633383 [revision_uid] => 2032 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

[summary] => [format] => 2 [safe_value] =>

Researchers from Ecole Polytechnique Fédérale of Lausanne (EPFL), Ca 'Foscari of Venice, and the University of Padua have established a method to sustainably produce and quickly identify thousands of macrocyclic compounds, a family of pharmaceutical molecules of great interest for the treatment of serious diseases such as tumors.

Published in Nature Communications, the study entitled Synthesis and direct assay of large macrocycle diversities by combinatorial late-stage modification at picomole scale show how acoustic wave technology allowed the parallel synthesis of multiple different chemical compounds in tiny reaction drops.

Most pharmaceutical research programs begin with a combinatorial process over many years in which a large number of structurally different chemical compounds are tested against a given target protein. Experiments are performed in plates containing hundreds of microwells that contain a chemical compound to be analyzed, ultimately yielding thousands of plates to study. A procedure that requires several days, huge costs, and high consumption of chemicals and which often does not lead to the identification of promising molecules.

To overcome this laborious and expensive process, a new method established how to synthesize large collections of compounds in extremely small volumes by rapidly mixing the reagents using acoustic waves. Thanks to miniaturization and high speed, research can sustainably generate a collection of more than tens of miles of different compounds in just half a day.

The technology synthesizes small macrocyclic compounds, which is a class of molecules capable of targeting specific disease-specific target proteins. These compounds mimic some naturally occurring molecules, such as the immunosuppressive cyclosporine, the antibiotic vancomycin, and the antitumor dactinomycin, and possess numerous qualities in which the pharmaceutical industry is particularly interested. For example, they have a low molecular weight, a property that allows them to pass through the cell membrane and reach targets inside the cell. In addition, their compact and rigid structure favors a high binding affinity with the target protein, thus allowing the use of a smaller amount of molecule to obtain the desired effect.

2022N23 Piano di emergenza ed evacuazione - prova pratica

Submitted by simonetta.capparotto on Mar, 12/07/2022 - 14:47

2022N23 Piano operativo colloquio

Submitted by simonetta.capparotto on Mar, 12/07/2022 - 14:45

2022N23 Piano operativo - prova pratica

Submitted by simonetta.capparotto on Mar, 12/07/2022 - 14:45

Censis 2022: the University of Padua once again ranked at the top of all mega universities

Submitted by francesca.forzan on Mar, 12/07/2022 - 14:31

Array ( [body] => Array ( [#theme] => field [#weight] => 0 [#title] => Body [#access] => 1 [#label_display] => hidden [#view_mode] => teaser [#language] => und [#field_name] => body [#field_type] => text_with_summary [#field_translatable] => 0 [#entity_type] => node [#bundle] => box_lancio_news [#object] => stdClass Object ( [vid] => 433682 [uid] => 2032 [title] => Censis 2022: the University of Padua once again ranked at the top of all mega universities [log] => [status] => 1 [comment] => 0 [promote] => 1 [sticky] => 0 [nid] => 91127 [type] => box_lancio_news [language] => it [created] => 1657629068 [changed] => 1692951274 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1692951274 [revision_uid] => 102 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>

Results from Censis ranking for Italian universities were published on Monday, July 11, confirming the University of Padua in second place under the category dedicated to mega-state universities.

The ranking developed by Censis is based on criteria that take into consideration available facilities, student services, and scholarships, as well as the level of internationalization of the student community, postgraduate employability, and the effectiveness of communication services.

Under such criteria, the University of Padua achieves high scores on all six parameters. Reaching excellence scores in communication and digital services, which assesses the functionality and content of its web portals, and high scores for employment rates of graduates one year after graduation, ranking second only to the University of Milan.

These results highlight how the strategies implemented by the University of Padua once again have led to the enhancement of the excellence of the university system.